Dynamic changes in striatal dopamine D2 and D3 receptor protein and mRNA in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) denervation in baboons

Journal of Neuroscience

Volumn 16, Issue 23, 1996, Pages 7776-7782

  Todd, Richard D ^a   Carl, Juanita ^a,b   Harmon, Steven ^a   O'Malley, Karen L ^a   Perlmutter, Joel S ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

caudate; dopamine D2 receptor; dopamine D3 receptor; MPTP; Parkinson's disease; putamen

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BABOON; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DENERVATION; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PUTAMEN; RECEPTOR BINDING;

EID: 0029860816     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-23-07776.1996     Document Type: Article

References (42)

1. Alexander GM, Brainard DL, Gordon SW, Hichens M, Grothusen JR, Schwartzman RJ (1991) Dopamine receptor changes in untreated and (+)-PHNO-treated MPTP parkinsonian primates. Brain Res 547:181-189.
2. 3 subtypes. Brain Res 649:95-110.
3. Ballard PA, Tetrud JW, Langston JW (1985) Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology 35:949-956.
4. Bankiewicz K, Oldfield E, Chiueh C, Doppman J, Jacobowitz D, Kopin I (1986) Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Sci 39:7-16.
5. Bergman H, Wichmann T, DeLong MR (1990) Reversal of experimental parkinsonism by lesions of subthalamic nucleus. Science 249:1436-1438.
6. 3 dopamine receptor: pharmacologic properties and development of antibodies. J Pharmacol Exp Ther 264:1002-1011.
7. Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin I (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 80:4546-4550.
8. A receptors in the striatopallidal complex. Brain Res 680:43-52.
9. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
10. 2 dopamine receptor density in MPTP monkeys. Neurosci Lett 86:225-229.
11. 2 dopamine receptor protein location: Golgi impregnation-gold toned and ultrastructural analysis of the rat neostriatum. J Neurosci Res 38:551-564.
12. Fornaretto MG, Caccia C, Caron MG, Fariello RG (1993) Dopamine receptors status after unilateral nigral 6-OHDA lesion. Autoradiographic and in situ hybridization study in the rat brain. Mol Chem Neuropathol 19:147-162.
13. Gagnon C, Bédard PJ, Di Paolo T (1990) Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists. Eur J Pharmacol 178:115-120.
14. Grandy DK, Civelli O (1992) G-protein coupled receptors: the new dopamine receptor subtypes. Curr Opin Neurobiol 2:275-281.
15. Guttman M, Fihiger HC, Jakubovic A, Calne DB (1990) Intracarotid 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration: biochemical and behavioral observations in a primate model of hemiparkinsonism. J Neurochem 543:1329-1334.
16. Hornykiewicz O (1963) Die Topische Lokalisation und das Verhalten von Noradrenalin und Dopamin in der Substantia Nigra des Normalen und Parkinsonkranken Menschen. Wien Klin Wochenscher 75:309-312.
17. Krug MS, Berger SL (1987) First strand cDNA synthesis primed with oligo(dT). Methods Enzymol 152:316-325.
18. 2-family receptor distribution in human postmortem tissue: an autoradiographic study. NeuroReport 6:2505-2512.
19. Langston JW, Balard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979-980.
20. Lau Y-S, Fung YK (1986) Pharmacological effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine receptor system. Brain Res 369:311-315.
21. 2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci USA 90:8861-8865.
22. A receptor gene: sequence homology with the rat and human genes and expression of alternative transcripts. J Neurochem 57:795-801.
23. 3 receptors: effects of ions and guanine nucleotides. J Pharmacol Exp Ther 274:790-797.
24. Miller Jr RG (1981) Simultaneous statistical inference. New York: Springer.
25. 4 receptors in GABAergic neurons of the primate brain. Nature 381:245-248.
26. 4 receptors. J Pharmacol Exp Ther 277:186-192.
27. 2A receptor gene: identification of alternative transcripts and a variant donor splice site. Biochemistry 29:1367-1371.
28. 4 receptor: sequence, gene structure and demonstration of expression in the cardiovascular system. New Biol 4:137-146.
29. Palombo E, Porrino LJ, Bankiewicz KS, Crane AM, SokolofF L, Kopin I (1990) Local cerebral glucose utilization in monkeys with hemiparkinsonism induced by intracarotid infusion of the neurotoxin MPTP. J Neurosci 10:860-869.
30. Parkinson D, Baughman R, Masland RH, Rando RR (1981) Dopmaine metabolism following irreversible inactivation of aromatic amino acid decarboxylase in retina. J Neurosci 1:1205-1210.
31. Perlmutter JS, Moerlein SM, Hwang D-R, Todd RD (1991) Non-steady-state measurement of in vivo radioligand binding with positron emission tomography: specificity analysis and comparison with in vitro binding. J Neurosci 11:1381-1389.
32. Perlmutter JS, Tempel LW, Lich L (1993) A new animal model of dystonia. Soc Neurosci Abstr 19:1052.
33. 2 dopamine receptors. J Neurochem 62:411-420.
34. 1 pituitary cells. FEBS Lett 312:123-126.
35. 4 receptors in Parkinson's, schizophrenia, and control brain striata. Synapse 14:247-253.
36. 3) as a target for neuroleptics. Nature 347:146-151.
37. 4 dopamine receptors in fibroblast and dopaminergic cell lines. J Pharmacol Exp Ther 268:495-502.
38. 3 receptors inhibit dopamine release. J Pharmacol Exp Ther 270:475-479.
39. 4 dopamine receptors in fibroblast and dopaminergic cell lines [erratum]. J Pharmacol Exp Ther 270:1397.
40. Weihmuller FB, Hadjiconstantinou M, Bruno JP (1989) Dissociation between biochemical and behavioral recovery in MPTP-treated mice. Pharmacol Biochem Behav 34:113-121.
41. Weihmuller FB, Bruno JP, Neff NH, Hadjiconstantinou M (1990) Dopamine receptor plasticity following MPTP-induced nigrostriatal lesions in the mouse. Eur J Pharmacol 180:369-372.
42. Wooten GF, Trugman JM (1989) The dopamine motor system. Movement Disorders 4:S38-S47.